Insider Selling: Rapid Micro Biosystems (NASDAQ:RPID) CFO Sells $22,782.06 in Stock

Rapid Micro Biosystems, Inc. (NASDAQ:RPID) CFO Sean Wirtjes sold 6,027 shares of the company’s stock in a transaction that occurred on Monday, February 9th. The stock was sold at an average price of $3.78, for a total value of $22,782.06. Following the completion of the transaction, the chief financial officer owned 483,928 shares of the company’s stock, valued at approximately $1,829,247.84. This represents a 1.23% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.

Rapid Micro Biosystems Trading Down 9.3%

RPID opened at $3.81 on Friday. The firm’s 50 day moving average is $3.66 and its 200-day moving average is $3.40. Rapid Micro Biosystems, Inc. has a 52-week low of $1.86 and a 52-week high of $4.94. The company has a quick ratio of 2.95, a current ratio of 4.23 and a debt-to-equity ratio of 0.42. The firm has a market capitalization of $168.86 million, a P/E ratio of -3.77 and a beta of 1.38.

Institutional Investors Weigh In On Rapid Micro Biosystems

Hedge funds and other institutional investors have recently modified their holdings of the stock. Hudson Bay Capital Management LP acquired a new stake in shares of Rapid Micro Biosystems in the 3rd quarter valued at about $38,000. American Century Companies Inc. increased its holdings in Rapid Micro Biosystems by 46.1% in the second quarter. American Century Companies Inc. now owns 16,922 shares of the company’s stock valued at $58,000 after buying an additional 5,341 shares during the last quarter. Nano Cap New Millennium Growth Fund L P acquired a new stake in Rapid Micro Biosystems during the fourth quarter valued at approximately $72,000. XTX Topco Ltd bought a new position in Rapid Micro Biosystems during the 2nd quarter worth approximately $144,000. Finally, Goldman Sachs Group Inc. acquired a new position in shares of Rapid Micro Biosystems in the 4th quarter worth approximately $160,000. Institutional investors own 52.60% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts have commented on the stock. Wall Street Zen lowered shares of Rapid Micro Biosystems from a “hold” rating to a “sell” rating in a report on Saturday, January 17th. Weiss Ratings reiterated a “sell (d-)” rating on shares of Rapid Micro Biosystems in a research note on Thursday, January 22nd. One research analyst has rated the stock with a Buy rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $8.00.

Rapid Micro Biosystems Company Profile

Rapid Micro Biosystems (NASDAQ: RPID) develops and commercializes automated microbial detection and contamination control solutions for the life sciences industry. Its flagship offering, the Growth Direct® System, leverages digital imaging and proprietary growth indicator plates to identify and count microorganisms more rapidly than traditional culture-based methods. The company’s technology platform is designed to streamline quality control workflows in pharmaceutical, biotechnology and vaccine manufacturing settings, helping clients reduce release times and improve operational efficiency.

In addition to the Growth Direct® System, Rapid Micro Biosystems offers an integrated suite of software and consumables that support automated data capture, analysis and reporting.